News
Natural killer cells dressed to kill cancer cells
A new study may potentially enable scientists to provide cancer immunotherapy that is cheaper, faster and more manageable.
The Incubator Labs are expanding
The laboratories at Oslo Cancer Cluster Incubator are expanding to meet increasing demand from members.
Attracting clinical trials to Norway
Dr. Jon Amund Kyte at Oslo University Hospital aims to bring more and better clinical trials to Norway.
Promising start for expansion group of Targovax clinical trial
Targovax, one of the members of Oslo Cancer Cluster, has begun an expansion patient group in the clinical trial of a drug to treat skin cancer. The company Targovax is developing immune activators to target solid tumours that are difficult to treat. The drug in question, called ONCOS-102, is aimed at patients with malignant melanoma (skin […]
New collaboration aims to treat cervical cancer
Vaccibody and Roche have started a new collaboration to investigate a drug combination for patients with advanced cervical cancer.
Operation fruit flies
Pupils from Ullern Upper Secondary School got to experience how cancer researchers look at fruit flies.
Top presentations from Cancer Crosslinks 2019
All the Cancer Crosslinks 2019 presentations on video.
Why a logistics company joined the cluster
Why did a logistics company join a cluster dedicated to cancer treatment?
Getting genomics into healthcare: look to the UK
During Cancer Crosslinks 2019 one thing was crystal clear: there is a need to include broader genomic testing into treatments for cancer patients in Norway.
Why a Nordic mentor network is a good idea
Why is a Nordic mentor network a good idea for Norwegian start ups working in cancer?
Cancer Crosslinks LIVE streaming
Today, Thursday 17 January, we broadcast LIVE from our conference Cancer Crosslinks at Oslo Cancer Cluster Innovation Park.
New research: 3D structure tumors in immunotherapy
New research could help to streamline the development of exciting new immunotherapy approaches for treating cancer.
